Advancing Education, Research, and Quality of Care for the Head and Neck oncology patient.
A conversation with Ravindra Uppaluri, MD, PhD “Neoadjuvant Therapy for Advanced H&N Mucosal Carcinoma” with Sagar Kansara, MD
Presented by the AHNS Population & Health Clinical Research Service
The end of April Head and Neck Cancer Awareness month approaches, please spread awareness about Oral Cancer where early detection will save lives and improve outcomes! Signs and symptoms that should prompt medical attention include 1. Growing bump in the mouth 2. Persistent sores or white or red patches 3. Persistent pain or difficulty speaking or swallowing 4. Oral bleeding or numbness
April is National CBD Awareness Month! Many patients with head & neck cancer have questions about the evidence regarding the use of cannabis and cannabidiol. This infographic offers facts about cannabis, CBD, and head & neck cancer.
Members of the AHNS Cancer Prevention Service contributing to this issue:
Andrew Holcomb, MD (service chair); Heather Edwards, MD (service vice chair); John Cramer, MD; Apurva Garg, MBBS, MS; James Gates, DMD MD.
Click the image below to access this issue of AHNS Journal Club
This Joint presentation by the American Head & Neck Society and the Head & Neck Cancer Alliance is offered to increase awareness of approaches to nasopharyngeal cancer treatment and the importance of survivorship. This session will highlight common acute and chronic treatment-related side effects as well as the importance of clinical trials in managing cancer recurrence.
Moderator:
Alice Lin, MD, Kaiser Permanente
Panelists:
Hyu Kang, MD, MPH, FACP, UCSF – Medical Oncologist
Mark McDonald, MD, Emory University – Radiation Oncologist
Lisa Evangelista, CScD CCC-SLP BCS-S, UC Davis – Speech-Language Pathologist
Brad Johnson, 20-year cancer survivor
Dr. Michelle Wan, 3-year cancer survivor
